Olodaterol
| Evidence Level: N/A | Predicted Indications: 0 |
Table of Contents
Olodaterol
Quick Overview
| Item | Content |
|---|---|
| Original Indication | Not recorded in the local data |
| Canada Market Status | Marketed (marketed DINs: 1 of 1) |
| Number of DINs | 1 (marketed: 1) |
Canada Market Information
| DIN | Product Name | Dosage Form | Approved Indication |
|---|---|---|---|
| 02441888 | INSPIOLTO RESPIMAT | Not available | Not available |
This is the only authorisation on record (status: valid).
Safety Considerations
- Drug Interactions: 100 interactions were identified in the interaction database, and all of those displayed are rated Moderate. Main examples:
- Sympathomimetics (additive adrenergic effects): epinephrine (including ophthalmic and topical forms), ephedrine (including nasal), isometheptene, diethylpropion, phentermine, fenfluramine
- QT-relevant agents: clarithromycin, cisapride, dolasetron, palonosetron, granisetron
- Glucose-lowering agents: canagliflozin, ertugliflozin, albiglutide, semaglutide
- Others: famotidine, loperamide
Please refer to the package insert for key warnings and contraindications.
Disclaimer
This content is for research purposes only and does not constitute medical advice. Clinical validation is required before any clinical application.